Literature DB >> 7754014

Superconducting open-configuration MR imaging system for image-guided therapy.

J F Schenck1, F A Jolesz, P B Roemer, H E Cline, W E Lorensen, R Kikinis, S G Silverman, C J Hardy, W D Barber, E T Laskaris.   

Abstract

PURPOSE: To develop a superconducting magnetic resonance (MR) imager that provides direct access to the patient and permits interactive MR-guided interventional procedures.
MATERIALS AND METHODS: A 0.5-T superconducting magnet that allows a region of vertical access to the patient was designed and constructed. This magnet was integrated with newly designed shielded gradient coils, flexible surface coils, and nonmagnetic displays and with position-monitoring probes and device-tracking instrumentation.
RESULTS: The magnet homogeneity was 12.3 ppm, and the gradient field was linear to within 1% over an imaging region 30 cm in diameter. The signal-to-noise ratio was 10% higher than in a comparable 0.5-T superconducting imager. Images were obtained in several anatomic regions with use of routine pulse sequences. Interactive image plane selection and near real-time imaging, with use of fast gradient-recalled echo sequences, were demonstrated at a rate of one image every 1.5 seconds.
CONCLUSION: MR-guided interventional procedures can be performed with full patient access with use of an open-configuration, superconducting MR magnet with near real-time imaging and interactive image plane control.

Entities:  

Mesh:

Year:  1995        PMID: 7754014     DOI: 10.1148/radiology.195.3.7754014

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  23 in total

Review 1.  Ablative therapy for liver tumours.

Authors:  E A Dick; S D Taylor-Robinson; H C Thomas; W M W Gedroyc
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 2.  MR-guided microwave ablation for malignancies.

Authors:  Yoshimasa Kurumi; Tohru Tani; Shigeyuki Naka; Hisanori Shiomi; Tomoharu Shimizu; Hajime Abe; Yoshihiro Endo; Shigehiro Morikawa
Journal:  Int J Clin Oncol       Date:  2007-04-27       Impact factor: 3.402

Review 3.  MR-guided prostate interventions.

Authors:  Clare Tempany; Sarah Straus; Nobuhiko Hata; Steven Haker
Journal:  J Magn Reson Imaging       Date:  2008-02       Impact factor: 4.813

4.  Quantitative comparison of functional MRI and direct electrocortical stimulation for functional mapping.

Authors:  S Larsen; R Kikinis; I-F Talos; D Weinstein; W Wells; A Golby
Journal:  Int J Med Robot       Date:  2007-09       Impact factor: 2.547

5.  Intraoperative 3T MR imaging for spinal cord tumor resection: feasibility, timing, and image quality using a "twin" MR-operating room suite.

Authors:  T P Duprez; A Jankovski; C Grandin; L Hermoye; G Cosnard; C Raftopoulos
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-10       Impact factor: 3.825

Review 6.  Enabling Technology for MRI-Guided Intervention.

Authors:  Farzad Sedaghat; Kemal Tuncali
Journal:  Top Magn Reson Imaging       Date:  2018-02

7.  Controlling radiofrequency-induced currents in guidewires using parallel transmit.

Authors:  Maryam Etezadi-Amoli; Pascal Stang; Adam Kerr; John Pauly; Greig Scott
Journal:  Magn Reson Med       Date:  2014-12-17       Impact factor: 4.668

8.  Gross-total surgery of supratentorial low-grade gliomas under intraoperative MR guidance.

Authors:  J P Schneider; T Schulz; F Schmidt; J Dietrich; S Lieberenz; C Trantakis; V Seifert; S Kellermann; R Schober; L Schaffranietz; M Laufer; T Kahn
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

9.  Dual-room 1.5-T intraoperative magnetic resonance imaging suite with a movable magnet: implementation and preliminary experience.

Authors:  Xiaolei Chen; Bai-nan Xu; Xianghui Meng; Jun Zhang; Xingguang Yu; Dingbiao Zhou
Journal:  Neurosurg Rev       Date:  2011-06-15       Impact factor: 3.042

10.  Origins of intraoperative MRI.

Authors:  John M K Mislow; Alexandra J Golby; Peter M Black
Journal:  Magn Reson Imaging Clin N Am       Date:  2010-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.